Search Tag: dabigatran

Cardiology Management

2017 24 Oct

Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation (AFib), but this therapy is associated with a high risk of bleeding. Researchers conducted a randomised trial ("RE-DUAL PCI") to compare the use of two regimens of dual...Read more

Cardiology Management

2014 05 Nov

According to a new study published in JAMA Internal Medicine , patients with atrial fibrillation who take the blood thinner dabigatran are at higher risk for major bleeding and gastrointestinal bleeding than those who take warfarin. The findings indicate that more caution is needed when prescribing dabigatran to certain high-risk patients, said researchers...Read more